Feb. 28 at 4:05 PM
$TKNO — Alpha Teknova 🧬⚗️
Rounded bottom breakout. Fresh earnings. Analyst target
$9.00.
The chart and fundamentals just aligned perfectly.
📊 RSI 51 — dead center, maximum room to run
📊 ADX rolling over from highs — downtrend exhausting
📊 OBV turning up — accumulation beginning
📊 Cup formation measured move: 58% upside toward
$4.20
Q4 2025 earnings dropped YESTERDAY:
✅ 7th consecutive quarter of revenue growth
✅ 2026 revenue guided
$42–
$44M
✅ Free cash outflow cutting to under
$10M
✅ EBITDA positivity target: end of 2027
✅ Fortress balance sheet — current ratio 5.27, debt/equity 0.4
✅ 70% incremental gross margin leverage — operating leverage is massive
✅ Zero analyst sell ratings. Avg target:
$9.00
The invisible backbone of biotech. 3,000+ customers. No one talks about it.
Key levels:
🟢 Hold above
$2.26 — cup structure intact
🎯 Targets:
$3.00 →
$3.54 →
$4.20
🔴 Lose
$2.15 on a close — setup off the table
#TKNO #AlphaTeknova #Biotech #Reagents #CupAndHandle #TechnicalAnalysis #Breakout
